A novel clinical trial aims to study the combined effect of Poly-L-lactic Acid (PLLA) and microneedling for treating perioral wrinkles. Sponsored by Skincare Physicians of Chestnut Hill and Galderma R&D, this new study is a promising development for skincare innovation. While enrollment has not yet begun, clinical, quality, and regulatory teams should monitor updates closely.
In this article:
- What are the trial details?
- How does Poly-L-lactic Acid work?
- Why combine PLLA with microneedling?
- FAQ
- Conclusion
- Disclaimer
- Find out more
What are the trial details?
The trial will test the effects of a topical application of Poly-L-lactic Acid in conjunction with microneedling on perioral wrinkles. This area, known for its challenges in cosmetic dermatology, often requires advanced approaches for meaningful results.
The study is registered on ClinicalTrials.gov but has not yet opened for recruitment. The sponsors, renowned skincare organizations, aim to measure efficacy, safety, and device performance under controlled conditions.
How does Poly-L-lactic Acid work?
Poly-L-lactic Acid, commonly referred to as PLLA, is a biocompatible polymer known for its collagen-stimulating properties. It has long been used in dermal treatments to enhance skin texture and elasticity. As a gradual collagen booster, PLLA supports structural improvements over time.
The topical formulation explored in this trial intends to deliver these benefits directly to the targeted area, thereby addressing fine lines and wrinkles.
Why combine PLLA with microneedling?
Microneedling is a minimally invasive procedure that stimulates natural wound-healing processes by creating microscopic skin punctures. This technique enhances transdermal absorption of active agents like Poly-L-lactic Acid.
By pairing PLLA’s collagen-generating effect with microneedling’s delivery method, the trial seeks to maximize efficacy in treating challenging wrinkles around the mouth.
FAQ
- Who are the sponsors?
The study is backed by Skincare Physicians of Chestnut Hill and Galderma R&D. - Is the trial recruiting participants?
No, the trial is currently marked as “Not yet recruiting.” - What makes the combination of PLLA and microneedling unique?
This dual approach aims to boost collagen production effectively while optimizing skin absorption through microneedling. - Where can I find enrollment updates?
Enrollment and updates can be tracked on ClinicalTrials.gov.
Conclusion
Advances in cosmetic dermatology rely on innovative research like this upcoming clinical trial. The combination of Poly-L-lactic Acid and microneedling represents a promising path to address perioral wrinkles. Industry professionals should stay informed about trial progress and potential regulatory milestones.
Disclaimer
This article is for informational purposes only and is not intended as legal advice. Consult appropriate regulatory and legal professionals regarding compliance and clinical trial procedures.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07225348?term=medical+device